OAC
BSX icon

OMERS Administration Corp’s Boston Scientific BSX Stock Holding History

OMERS Administration Corp’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
84,750
+4,814
+6% +$261K 0.02% 425
2026
Q1 		$5.02M Buy
79,936
+5,326
+7% +$426K 0.03% 239
2025
Q4 		$7.11M Buy
74,610
+19,383
+35% +$1.9M 0.05% 146
2025
Q3 		$5.39M Hold
55,227
– – 0.04% 176
2025
Q2 		$5.93M Buy
55,227
+500
+0.9% +$50.6K 0.05% 146
2025
Q1 		$5.52M Sell
54,727
-6,569
-11% -$661K 0.05% 147
2024
Q4 		$5.47M Buy
61,296
+10,431
+21% +$918K 0.05% 150
2024
Q3 		$4.26M Sell
50,865
-32,800
-39% -$2.59M 0.04% 184
2024
Q2 		$6.44M Buy
+83,665
New +$6.12M 0.06% 138
2023
Q2 		– Sell
-4,111,160
Closed -$206M – 242
2023
Q1 		$206M Hold
4,111,160
– – 3.17% 7
2022
Q4 		$190M Hold
4,111,160
– – 3.05% 5
2022
Q3 		$159M Buy
4,111,160
+1,624,700
+65% +$65.2M 2.66% 9
2022
Q2 		$92.7M Sell
2,486,460
-1,000,700
-29% -$40.7M 1.34% 35
2022
Q1 		$154M Hold
3,487,160
– – 1.98% 19
2021
Q4 		$148M Buy
3,487,160
+824,549
+31% +$34.6M 1.92% 17
2021
Q3 		$116M Buy
2,662,611
+16,200
+0.6% +$717K 1.68% 23
2021
Q2 		$113M Buy
2,646,411
+36,134
+1% +$1.52M 1.62% 23
2021
Q1 		$101M Sell
2,610,277
-498,362
-16% -$18.9M 1.6% 20
2020
Q4 		$112M Buy
3,108,639
+1,369,774
+79% +$49.4M 2.02% 15
2020
Q3 		$66.4M Buy
1,738,865
+98,251
+6% +$3.79M 1.4% 21
2020
Q2 		$57.6M Buy
+1,640,614
New +$59.1M 1.91% 13
2014
Q4 		– Sell
-237,300
Closed -$2.8M – 401
2014
Q3 		$2.8M Sell
237,300
-9,700
-4% -$122K 0.08% 143
2014
Q2 		$3.15M Hold
247,000
– – 0.1% 126
2014
Q1 		$3.34M Hold
247,000
– – 0.11% 112
2013
Q4 		$2.97M Sell
247,000
-223,400
-47% -$2.64M 0.11% 97
2013
Q3 		$5.52M Buy
470,400
+187,400
+66% +$2.03M 0.52% 49
2013
Q2 		$2.62M Buy
+283,000
New +$2.4M 0.24% 78

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OMERS Administration Corp's BSX Position: Q2 2026 in Review

OMERS Administration Corp increased its Boston Scientific (BSX) stake by 6% in Q2 2026, buying an estimated $261K and bringing the position to 84,750 shares worth $3.62M. The position accounts for 0.02% of the portfolio, ranked #425.

OMERS Administration Corp first reported a position in BSX in Q2 2013 and has held it in 27 quarters since. The position peaked at $206M in Q1 2023. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • OMERS Administration Corp held 84,750 shares of Boston Scientific worth $3.62M as of Q2 2026.
  • OMERS Administration Corp bought 4,814 Boston Scientific shares in Q2 2026, an estimated $261K.
  • Boston Scientific made up 0.02% of OMERS Administration Corp's portfolio in Q2 2026, its #425 holding.
  • OMERS Administration Corp first reported a position in Boston Scientific in Q2 2013 and has held it in 27 quarters since.
  • OMERS Administration Corp's Boston Scientific position peaked at $206M in Q1 2023.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.